Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.

Sven DittrichErika GrafRegina TrollmannUlrich NeudorfUlrike ScharaAntje HeilmannMaja von der HagenBrigitte StillerJanbernd KirschnerRobert Dalla PozzaWolfgang Müller-FelberKatja WeissKatja von AuMarkus KhalilReinald MotzChristoph KorenkeMartina LangeEkkehard WilichowskiJoseph PattathuFriedrich EbingerNicola WiechmannRolf Schrödernull null

Published in: Orphanet journal of rare diseases (2019)

DRKS-number 00000115, EudraCT-number 2009-009871-36.

Keyphrases

duchenne muscular dystrophy
double blind
left ventricular
clinical trial
angiotensin converting enzyme
placebo controlled
heart failure
study protocol
oxidative stress
acute myocardial infarction
randomized controlled trial
cardiac resynchronization therapy
coronary artery disease
phase iii